Jasveen Sangha, the “Ketamine Queen,” pleads guilty to charges in Matthew Perry’s fatal overdose, marking the final plea in the U.S. case.
High-Profile Case Reaches Final Chapter
Jasveen Sangha, known in court filings as the “Ketamine Queen,” has agreed to plead guilty to federal drug charges in connection with actor Matthew Perry’s fatal overdose. She becomes the fifth and final defendant in the case to avoid trial by striking a plea deal with U.S. prosecutors.
Court Filing in Los Angeles
The guilty plea agreement was submitted in federal court in Los Angeles on August 18, 2025. Sangha, a dual citizen of the U.S. and U.K., will formally change her plea at an upcoming hearing, where a sentencing date will be set. Perry, best known for his role as Chandler Bing on Friends, died at his Los Angeles home on October 28, 2023, from acute ketamine effects.
Charges and Potential Sentence
According to prosecutors, Sangha admitted to one count of maintaining a drug-involved premises, three counts of distributing ketamine, and one count of distribution resulting in death or serious injury. The charges carry a maximum penalty of 45 years in prison, though the prosecution has indicated it will seek less than the maximum.
Evidence and Supply Chain
Court documents state that Sangha sold dozens of vials of ketamine through intermediaries to Perry in the weeks leading up to his death. Messages presented in evidence show that she urged contacts to delete records of the drug deals on the day Perry died. Prosecutors allege that Perry’s assistant and acquaintances helped facilitate the transactions.
Wider Investigation and Co-Defendants
This plea concludes a year-long investigation that led to charges against five people, including two doctors and Perry’s assistant. Each of the co-defendants has already entered guilty pleas, providing testimony that implicated Sangha as a central figure in the drug supply chain. None of the defendants have yet been sentenced.
Broader Significance for Public Health
Perry, who openly discussed his struggles with addiction, had been undergoing ketamine therapy prescribed legally for depression. Prosecutors argue that Sangha exploited this vulnerability by supplying additional, unregulated doses. For Canadians following the case, the resolution highlights the ongoing dangers of illicit drug distribution, particularly when intertwined with celebrity culture and medical loopholes.
For continuous coverage and real-time updates, keep following Maple News Wire.
